Topia Life Sciences developed e-CTD Plus, a modern regulatory submission platform that simplifies the preparation and management of documents for pharmaceutical and life sciences enterprises. By delivering a strong, user-friendly system that meets global regulatory standards, e-CTD Plus provides efficient, compliant, and smooth submissions, resulting in speedier approval processes.
Whether you are a large pharmaceutical manufacturer, a small biotech company, or a contract manufacturer, e-CTD Plus adapts to your specific needs, providing flexibility and precision when navigating difficult regulatory regulations
At Topia Life Sciences, we are committed to developing significant solutions that enhance regulatory submission procedures, allowing firms to focus on bringing lifesaving products to market. e-CTD Plus exemplifies our commitment to simplify compliance while expediting medication development and clearance.
Embracing diversity, valuing ethics, and promoting better results for everyone.
Include pushing limitations, flourishing in a fast-paced atmosphere, and encouraging progress.
Entails breaking the mold, addressing challenges, and evolving together.
Entails prioritising safety, being meticulous, and always putting patients first.
e-CTD Plus is more than just a submission tool—it’s a comprehensive solution for businesses that need to manage complex regulatory requirements with ease. By centralising document preparation, automating validation, and simplifying workflows, e-CTD Plus empowers you to focus on what matters most: bringing your product to market quickly and compliantly.
"Through the advancement of our platforms, we will build a fully integrated data economy. At Topia Life Sciences, we are passionate about improving health outcomes for people around the world."
- Kamlesh Patel, Founder